Pharm/Biotech
Resources

Outsourcing Guide

Cont. Education

Software/Reports

Training Courses

Web Seminars

Jobs

Buyer's Guide

Home Page

Pharm Patents /
Licensing

Pharm News

Federal Register

Pharm Stocks

FDA Links

FDA Warning Letters

FDA Doc/cGMP

Pharm/Biotech Events

Consultants

Advertiser Info

Newsletter Subscription

Web Links

Suggestions

Site Map
 

 

 

 

Title:  Diketopiperazine-based delivery systems

United States Patent:   5,976,569

Inventors:  Milstein; Sam J. (Larchmont, NY)

Assignee:  Emisphere Technologies, Inc. (Tarrytown, NY)

Appl. No.:  841101

Filed:  April 29, 1997

Abstract

Compositions useful in the delivery of active agents are provided. These delivery compositions include (a) an active agent; and either (b)(1) a carrier of (i) at least one amino acid and (ii) at least one diketopiperazine or (b)(2) at least one mono-N-substituted, di-N-substituted, or unsubstituted diketopiperazine. Methods for preparing these compositions and administering these compositions are also provided.

SUMMARY OF THE INVENTION

Compositions useful in the delivery of active agents are provided. These delivery compositions comprise (a) an active agent; and (b) a carrier comprising (i) at least one amino acid or an ester or an amide thereof and (ii) at least one diketopiperazine. Preferably, the carrier comprises (i) at least two amino acids which are the same or different and (ii) at least one diketopiperazine. In an alternate embodiment, the delivery compositions comprise (a) an active agent, and (b) at least one mono-N-substituted, di-N-substituted, or unsubstituted diketopiperazine.

Biologically active agents and pharmacologically active agents may be incorporated as the active agent, and these compositions may be in the form of microspheres.

Also contemplated is a method for preparing these compositions wherein at least one active agent is mixed with a carrier as described above or wherein the carrier is solubilized in a solvent, and the carrier solution is contacted with the active agent and a precipitator solution in which the carrier is insoluble.

In a further embodiment, the compositions are administered, preferably orally, to animals.

Claim 1 of 38 Claims

1. A delivery composition comprising:

(a) an active agent; and

(b) a diketopiperazine having the formula:

wherein R1, R2, or R1 and R2 independently are hydrogen, C1 -C24 alkyl, C1 -C24 alkenyl, phenyl, naphtyl, (C1 -C10 alkyl)phenyl, (C1 -C10 alkenyl)phenyl, (C1 -10 alkyl)naphthyl, (C1 -C10 alkenyl)naphthyl, phenyl (C1 -C10 alkyl), phenyl (C1 -C10 alkenyl), naphthyl (C1 -C10 alkyl), and naphthyl (C1 -C10 alkenyl);

R1 or R2, or both R1 and R2, optionally, are independently substituted with C1 -C4 alkyl, C1 -C4 alkenyl, C1 -C4 alkoxy, --OH, --SH, and --CO2 R3 or any combination thereof; wherein R3 is hydrogen, C1 -C4 alkyl, or C1 -C4 alkenyl;

R1, R2, or R1 and R2, optionally, are independently interrupted by oxygen, nitrogen, sulfur, or any combination thereof;

said phenyl, naphthyl, or phenyl and naphthyl groups, optionally, are independently substituted by C1 -C6 alkyl, C1 -C6 alkenyl, C1 -C6 alkoxy, --OH, --SH, or CO2 R4 wherein R4 is hydrogen, C1 -C6 alkyl; or C1 -C alkenyl; and

R1 and R2 are not both hydrogen.

____________________________________________
If you want to learn more about this patent, please go directly to the U.S. Patent and Trademark Office Web site to access the full patent.

 

 

[ Outsourcing Guide ] [ Cont. Education ] [ Software/Reports ] [ Training Courses ]
[ Web Seminars ] [ Jobs ] [ Consultants ] [ Buyer's Guide ] [ Advertiser Info ]

[ Home ] [ Pharm Patents / Licensing ] [ Pharm News ] [ Federal Register ]
[ Pharm Stocks ] [ FDA Links ] [ FDA Warning Letters ] [ FDA Doc/cGMP ]
[ Pharm/Biotech Events ] [ Newsletter Subscription ] [ Web Links ] [ Suggestions ]
[ Site Map ]